Benitec Biopharma (BNTC) Misses Q2 EPS by 264c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BNTC Hot Sheet
Join SI Premium – FREE
Benitec Biopharma (NASDAQ: BNTC) reported Q2 EPS of ($2.64).
For earnings history and earnings-related data on Benitec Biopharma (BNTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cirrus Logic, Inc. (CRUS) Tops Q2 EPS by 27c; offers guidance
- Marriott International (MAR) PT Lowered to $141 at Jefferies
- Berkshire Hathaway hits 52-week high on election rally
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
